IN 1974 A SURVEY of the world's leading biopharmacists and pharmacokineticists found that only five out of seventeen agreed with the definition of the term biopharmaceutics. Twelve of the seventeen scientists either limited, expanded, or otherwise modified the term in such a way as to give it a completely different meaning. Among the twelve scientists defining the term biopharmaceutics, there were so many variations and interpretations of meaning that confusion could be the only possible result. Additional complexity and confusion resulted from improper translations from one language to another.
Recognizing this problem, participants in two International Symposia on Biopharmaceutics and Pharmacokinetics held in Czechoslovakia established a Task Force to draw up definitions of the most important concepts in biopharmaceutics and pharmacokinetics and to obtain their general acceptance. A detailed progress report of this Task Force, which is headed by Professor Zadiureck^ of the Institute of Experimental Pharmacology of the Slovak Academy of Sciences, is presented in an article beginning on page 281 of this issue.
Professor Zathurecky's group has prepared a list of sixty biopharmaceutic and pharmacokinetic terms and translated them into eighteen languages, all of which are included in his article. In addition, the Task Force has prepared definitions in English to these sixty terms and these accepted definitions are also included. The Task Force invites comments on its work and particularly on the definitions it has produced. Correspondents are 304 TERMINOLOGY invited to use the "Letters to the Editor" section of Drug Intelligence 6· Clinical Pharmacy for any comments they care to make. Copies of letters will be forwarded to Professor Zathurecky, whose response will be published. Thus, all interested parties will be able to participate in the dialogue.
Professor Zathurecky's article will also serve as a basic document for those working in the fields of biopharmaceutics and pharmacokinetics in other countries with other languages. One may expect that national working parties will be formed by the numerous language groups, and that they will translate the English definitions into their own languages, thus producing a worldwide standard terminology in biopharmaceutics and pharmacokinetics.
This may not be as easy a taslc as it might appear to be at first thought. Professor Zathurecky illustrates some of the difficulties that are encountered in his discussion of the different meanings given to three terms, biopharmaceutics, pharmacokinetics and bioavaüabüity, by various scientists working in different countries. As the author states, "Under these circumstances, a study of writings published in various scientific journals becomes extremely difficult."
Professor Zathurecky and his collaborators are to be commended for their efforts to develop a standard terminology in biopharmaceutics and pharmacokinetics and we hope that their efforts will receive the comment, discussion and final acceptance they deserve.
